Prescott General Partners LLC Long-Term Concentrated

CIK: 0001538653 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $1,801,802 (100.0% shares, 0.0% debt)

Holdings (7)

CACC CREDIT ACCEP CORP MICH 47.8%

Value ($000) $860,426 Shares 1,560,014 Est. Cost $107.75 Unrealized +409.2%

CMPR CIMPRESS PLC 19.2%

Value ($000) $345,764 Shares 3,906,492 Est. Cost $129.96 Unrealized -34.7%

WRLD WORLD ACCEP CORP DEL 16.4%

Value ($000) $295,396 Shares 2,037,495 Est. Cost $81.92 Unrealized +60.2%

W WAYFAIR INC 14.4%

Value ($000) $259,521 Shares 3,823,239 Est. Cost $53.95 Unrealized +4.8%

YELP YELP INC 2.0%

Value ($000) $36,187 Shares 918,446 Est. Cost $30.67 Unrealized +35.1%

LCTX LINEAGE CELL THERAPEUTICS IN 0.2%

Value ($000) $2,741 Shares 1,851,851 Est. Cost $1.03 Unrealized +10.0%

HUMA HUMACYTE INC 0.1%

Value ($000) $1,767 Shares 568,246 Est. Cost $6.34 Unrealized -47.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CACC	CREDIT ACCEP CORP MICH	1,560,014	$860,426	47.8%	$107.75	+409.2%	COM	225310101
CMPR	CIMPRESS PLC	3,906,492	$345,764	19.2%	$129.96	-34.7%	SHS EURO	G2143T103
WRLD	WORLD ACCEP CORP DEL	2,037,495	$295,396	16.4%	$81.92	+60.2%	COM	981419104
W	WAYFAIR INC	3,823,239	$259,521	14.4%	$53.95	+4.8%	CL A	94419L101
YELP	YELP INC	918,446	$36,187	2.0%	$30.67	+35.1%	CL A	985817105
LCTX	LINEAGE CELL THERAPEUTICS IN	1,851,851	$2,741	0.2%	$1.03	+10.0%	COM	53566P109
HUMA	HUMACYTE INC	568,246	$1,767	0.1%	$6.34	-47.0%	COM	44486Q103